Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q3 2021
Institutional positions in Cidara Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- −5 vs. Q2 2021
- Shares held
- 18.8M
- −1.23M (−6.2%) vs. Q2 2021
- Total value
- $42.1M
- +$1.64M (+4.1%) vs. Q2 2021
- New holders
- 8
- 12 more added
- Sold out
- 13
- 16 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 15 | $0 | 0.00% | −5,981−99.7% | Reduced |
| Wells Fargo & Company | 240 | $1.00K | 0.00% | −30−11.1% | Reduced |
| BNP Paribas Arbitrage, SA | 710 | $1.59K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,559 | $5.00K | 0.00% | −61,123−96.0% | Reduced |
| Optiver Holding B.V. | 5,090 | $11.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,881 | $11.0K | 0.00% | +4,881 | New |
| Morgan Stanley | 7,108 | $16.0K | 0.00% | +4,169+141.9% | Added |
| Bollard Group LLC | 7,733 | $17.0K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 8,000 | $18.0K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10,000 | $22.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 11,443 | $26.0K | 0.00% | −14,079−55.2% | Reduced |
| Group One Trading, L.P. | 11,548 | $26.0K | 0.00% | +11,548 | New |
| Dimensional Fund Advisors LP | 12,326 | $28.0K | 0.00% | +12,326 | New |
| Russell Investments Group, Ltd. | 17,100 | $38.0K | 0.00% | 00.0% | Unchanged |
| Aveo Capital Partners, LLC | 22,502 | $50.0K | 0.01% | +22,502 | New |
| Occudo Quantitative Strategies LP | 23,696 | $53.0K | 0.01% | −8,223−25.8% | Reduced |
| Citadel Advisors LLC | 25,641 | $57.0K | 0.00% | +12,776+99.3% | Added |
| Kestra Advisory Services, LLC | 30,500 | $68.0K | 0.00% | +30,500 | New |
| Bank of America Corp | 36,013 | $81.0K | 0.00% | −5,772−13.8% | Reduced |
| HSBC Holdings PLC | 40,131 | $90.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 52,331 | $117.0K | 0.00% | +910+1.8% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 53,431 | $120.0K | 0.00% | +53,431 | New |
| Jeppson Wealth Management, LLC | 60,100 | $134.0K | 0.07% | +8,000+15.4% | Added |
| HRT Financial LP | 63,166 | $141.0K | 0.00% | −39,279−38.3% | Reduced |
| Northern Trust Corp | 69,722 | $156.0K | 0.00% | −2,706−3.7% | Reduced |
| State Street Corp | 73,000 | $164.0K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 87,419 | $196.0K | 0.00% | −31,063−26.2% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 89,342 | $200.0K | 0.00% | −4,997−5.3% | Reduced |
| Goldman Sachs Group Inc | 109,894 | $246.0K | 0.00% | −22,780−17.2% | Reduced |
| Bridgeway Capital Management, LLC | 118,878 | $266.0K | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 160,070 | $359.0K | 0.01% | −2,930−1.8% | Reduced |
| Marshall Wace, LLP | 184,027 | $412.0K | 0.00% | +184,027 | New |
| Artal Group S.A. | 224,675 | $503.0K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 318,149 | $713.0K | 0.00% | −262,644−45.2% | Reduced |
| BlackRock Inc. | 332,066 | $743.0K | 0.00% | −38,325−10.3% | Reduced |
| West Family Investments, Inc. | 368,910 | $826.0K | 0.22% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 369,099 | $827.0K | 0.15% | +369,099 | New |
| Two Sigma Investments, LP | 373,338 | $836.0K | 0.00% | +317,739+571.5% | Added |
| Geode Capital Management, LLC | 381,618 | $854.0K | 0.00% | +17,456+4.8% | Added |
| Knott David M | 415,308 | $930.0K | 0.39% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 468,594 | $1.05M | 0.00% | +428,000+1,054.3% | Added |
| Acadian Asset Management LLC | 586,848 | $1.31M | 0.01% | +161,874+38.1% | Added |
| Jacobs Levy Equity Management, Inc | 594,705 | $1.33M | 0.01% | +153,645+34.8% | Added |
| Stonepine Capital Management, LLC | 782,817 | $1.75M | 0.80% | −428,469−35.4% | Reduced |
| Renaissance Technologies LLC | 1,120,261 | $2.51M | 0.00% | +73,958+7.1% | Added |
| 5AM Venture Management, LLC | 1,134,511 | $2.54M | 0.52% | −872,000−43.5% | Reduced |
| Alethea Capital Management, LLC | 1,172,044 | $2.63M | 2.31% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,990,369 | $4.46M | 0.00% | +3,929+0.2% | Added |
| Omega Fund Management, LLC | 2,005,249 | $4.49M | 0.50% | 00.0% | Unchanged |
| BVF Inc | 4,776,904 | $10.7M | 0.42% | +430,000+9.9% | Added |
| Interwest Venture Management Co | 0 | $0 | 0.00% | −1,356,813−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −174,900−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −73,351−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −34,001−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −25,971−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −25,006−100.0% | Sold out |
| Pitcairn Co | 0 | $0 | 0.00% | −23,161−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,852−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −2,927−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,980−100.0% | Sold out |
| Isthmus Partners, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −283−100.0% | Sold out |